Anticancer Drug Delivery: An Update on Clinically Applied Nanotherapeutics

Drugs
Sophie MarchalLina Bezdetnaya

Abstract

The development of chemotherapy using conventional anticancer drugs has been hindered due to several drawbacks related to their poor water solubility and poor pharmacokinetics, leading to severe adverse side effects and multidrug resistance in patients. Nanocarriers were developed to palliate these problems by improving drug delivery, opening the era of nanomedicine in oncology. Liposomes have been by far the most used nanovectors for drug delivery, with liposomal doxorubicin receiving US FDA approval as early as 1995. Antibody drug conjugates and promising drug delivery systems based on a natural polymer, such as albumin, or a synthetic polymer, are currently undergoing advanced clinical trials or have received approval for clinical applications. However, despite attractive results being obtained in preclinical studies, many well-designed nanodrugs fell short of expectations when tested in patients, evidencing the gap between nanoparticle design and their clinical translation. The aim of this review is to evaluate the extent of nanotherapeutics used in oncology by providing an insight into the most successful concepts. The reasons that prevent nanodrugs from expanding to clinic are discussed, and the efforts that must be taken...Continue Reading

References

Oct 18, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·E M HiltboldO J Finn
Sep 6, 2001·Journal of Pharmaceutical Sciences·R B CampbellR M Straubinger
Aug 15, 2002·Journal of Controlled Release : Official Journal of the Controlled Release Society·Alexander V KabanovValery Yu Alakhov
May 17, 2003·Nature Reviews. Drug Discovery·Ruth Duncan
Sep 23, 2003·Advanced Drug Delivery Reviews·Michael L Graham
Nov 22, 2005·Journal of Controlled Release : Official Journal of the Controlled Release Society·Jack W Singer
Nov 17, 2006·Pharmaceutical Research·V P Torchilin
Nov 23, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Henri RochéBernard Asselain
Mar 27, 2007·Pharmaceutical Research·Damon SuttonJinming Gao
Aug 3, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Randeep Sangha, Charles Butts
Aug 28, 2007·International Journal of Nanomedicine·Stewart D ChipmanJack W Singer
Jan 1, 2008·Small·Nastassja LewinskiRebekah Drezek
Apr 22, 2008·Advanced Drug Delivery Reviews·Michael J HawkinsNeil Desai
Nov 1, 2008·Cancer Research·Vincent T DeVita, Edward Chu
Aug 7, 2009·The Breast : Official Journal of the European Society of Mastology·R C F LeonardS Oliveros
Aug 13, 2009·Advanced Drug Delivery Reviews·Gianfranco Pasut, Francesco M Veronese
Apr 29, 2010·Pharmaceutical Research·Gerben A KoningTimo L M ten Hagen
May 21, 2010·Paediatric Drugs·James E Frampton
May 22, 2010·Seminars in Thrombosis and Hemostasis·Janice A NagyHarold F Dvorak
Jun 10, 2010·Nanomedicine·Xiaowei Dong, Russell J Mumper
Aug 21, 2010·Pharmaceutical Research·Chris OerlemansWim E Hennink
Oct 23, 2010·Expert Opinion on Drug Delivery·Bhupender S Chhikara, Keykavous Parang
Feb 8, 2011·American Journal of Clinical Oncology·Thomas DipetrilloHoward Safran
Jul 5, 2011·Current Opinion in Biotechnology·Fabiana CanalMaría J Vicent
Jul 28, 2011·OncoTargets and Therapy·Yutaka YamamotoHirotaka Iwase
Oct 1, 2011·Journal of Controlled Release : Official Journal of the Controlled Release Society·Bakheet Elsadek, Felix Kratz
Oct 7, 2011·Molecular Pharmaceutics·Ruth Duncan, Rogerio Gaspar
Oct 11, 2011·Drug Discovery Today·Marije SlingerlandHans Gelderblom
Jun 7, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·William C ZamboniPiotr Grodzinski
Oct 6, 2012·Advanced Drug Delivery Reviews·Theresa M Allen, Pieter R Cullis
Dec 6, 2012·Cancer Chemotherapy and Pharmacology·Jeffrey A Silverman, Steven R Deitcher
Mar 20, 2013·Pharmacology & Therapeutics·Puja Sapra, Boris Shor
Apr 27, 2013·Drugs·Anita Ballantyne, Sohita Dhillon

❮ Previous
Next ❯

Citations

Jun 21, 2016·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Igor YankovskyVladimir Zorin
Oct 25, 2016·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Vahideh AlinejadMehdi Yousefi
Jul 6, 2016·ACS Applied Materials & Interfaces·Spencer L FennRachael A Floreani
Jul 19, 2016·Expert Opinion on Drug Delivery·Noura H Abd Ellah, Sara A Abouelmagd
Feb 6, 2017·Endocrine-related Cancer·Jenny G Parvani, Mark W Jackson
Jun 22, 2017·Biomacromolecules·Yuting ZhouXin Huang
Dec 27, 2017·Current Medical Research and Opinion·Nasimudeen R JabirShams Tabrez
Aug 2, 2017·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·Mohammad HedayatiRobert Ivkov
Oct 11, 2017·Monoclonal Antibodies in Immunodiagnosis and Immunotherapy·Yuriy K Bashmakov, Ivan M Petyaev
Jan 27, 2019·Therapeutic Delivery·Gizem BorAnan Yaghmur
Jan 11, 2020·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·Anilchandra AttaluriRobert Ivkov
Jun 8, 2017·Journal of Applied Toxicology : JAT·Hong SuMin Ding
Dec 4, 2019·Journal of Materials Science. Materials in Medicine·João Q CoentroYves Bayon
Dec 14, 2018·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·Sri Kamal KandalaRobert Ivkov
Jun 21, 2020·Angewandte Chemie·Xudong LiLichen Yin
Oct 3, 2020·Biotechnology and Applied Biochemistry·Elisa Fasoli
Dec 10, 2020·Pharmaceutics·Bárbara PintoHassan Bousbaa
Aug 26, 2019·Seminars in Cancer Biology·Sergey G KlochkovGjumrakch Aliev
Apr 21, 2017·Current Opinion in Chemical Biology·Anna E Czapar, Nicole F Steinmetz
Jul 8, 2019·Advanced Drug Delivery Reviews·Allison N DuRossConroy Sun
Apr 2, 2020·Materials Science & Engineering. C, Materials for Biological Applications·Amina Ben MihoubSamir Acherar
Aug 20, 2019·Current Medicinal Chemistry·Jia HouBin Chen
Dec 20, 2017·ACS Nano·Christopher M HartshornPiotr Grodzinski
Oct 8, 2021·Advanced Drug Delivery Reviews·Emma L EtterJuliane Nguyen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.